AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2024 Issue 4; ICD-10-PCS New/Revised Codes Section X – New Technology
Introduction of New Therapeutic Substances
In table XW0, Introduction of Anatomical Regions, 36 new substance values were added for the substances listed below. These substances have the qualifier value New Technology Group 10.Device/Substance/Technology 3 Bentracimab, Ticagrelor Reversal Agent 4 Cefepime-taniborbactam Anti-infective 5 Ceftobiprole Medocaril Anti-infective 6 Dasiglucagon 8 Obecabtagene Autoleucel 9 Odronextamab Antineoplastic B Orca-T Allogeneic T-cell Immunotherapy C Zanidatamab Antineoplastic D Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension F Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy G Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System H Paclitaxel-Coated Balloon Technology, One Balloon J Paclitaxel-Coated Balloon Technology, Two Balloons K Paclitaxel-Coated Balloon...
Subscribe or sign in to view the full article.
Article Overview
This article covers newly added therapeutic substance values in an inpatient procedure coding table and describes the clinical contexts in which those substances are used. It is relevant to hospital coders, coding educators, reimbursement staff, and clinical documentation teams who need to understand the scope of the update and the types of therapies included. The article presents high-level guidance on a set of new technology substance categories spanning anti-infective, antineoplastic, immunotherapy, cellular therapy, and other treatment areas.
Why This Topic Matters
Updates to therapeutic substance values can affect procedure reporting, documentation review, and code lookup workflows. Knowing which new substance categories were added helps coding and revenue cycle teams identify whether the article applies to their cases and systems.
Article Sections
-
New substance values added to table XW0
An overview of the update to the inpatient procedure table and the grouping used for the newly added substance values.
-
Therapeutic substance categories and clinical uses
High-level descriptions of the new substance categories and the general conditions or treatment areas associated with them.
What You Will Learn
- Which type of inpatient procedure table was updated
- What broad therapy categories were added
- Which clinical areas are associated with the new substances
- How the update may matter to coding and documentation workflows
Who Should Read This
- Hospital inpatient coders
- Coding auditors and educators
- Revenue cycle staff
- Clinical documentation specialists
- Health information management professionals
Code Ranges Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com